Skip to main content

Table 2 Pharmacokinetic parameters of buprenorphine after 0.0075 mg/kg bwt intravenously in ten horses

From: Nociceptive thermal threshold testing in horses – effect of neuroleptic sedation and neuroleptanalgesia at different stimulation sites

Horse

λz(h-1)

T1/2λ(h)

Vd(L/kg)

Cl (mL/min/kg)

AUC0-∞(h·ng/mL)

MRT (h)

1

0.12

7.02

3.89

6.40

19.54

6.98

2

0.06

12.09

1.88

1.80

69.39

12.48

3

0.06

8.86

2.90

3.78

33.12

9.25

4

0.12

5.59

0.83

1.71

72.93

5.12

5

0.12

6.79

1.03

1.76

71.17

6.54

6

0.18

3.51

0.56

1.84

67.91

3.47

7

0.06

9.89

3.07

3.59

34.81

11.96

8

0.12

6.85

0.92

1.56

80.33

7.61

9

0.18

4.30

1.69

4.55

27.47

5.09

10

0.12

7.47

3.74

5.78

21.62

9.56

Mean ± SD

0.11 ± 0.04

6.4 ± 2.63*

2.05 ± 1.25

3.28 ± 1.82

49.83 ± 24.37

7.81 ± 2.98

  1. λz, slope of the terminal phase; T1/2λ, half-life of terminal phase; Vd(area), volume of distribution; Cl, Clearance; AUC0-∞, area under the concentration-time curve extrapolated to infinity; MRT mean residence time. *Harmonic mean ± pseudo SD.